SRPT
Sarepta Therapeutics, Inc. · Healthcare
Director Michael Andrew Chambers bought $6.0M of Sarepta Therapeutics, Inc.
Bought$5,963,124
$104.43Price
57,100Shares
+45%Stake
What SRPT did for a copier
- $1,000 copied at Thu, Sep 15 open, $108.40
- $1,031
- S&P 500, same days
- −2.9%
Measured over 30 trading days, to the Oct 27 close.
Michael Andrew Chambers's record
4 other buys with 3 months of prices since 2022: on average −17.7% against the S&P 500, and 1 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Sep 14. Filed Thu, Sep 15, 8:00 AM ET, before the open. Returns use the Sep 15 open and the Oct 27 close. Not investment advice.